Abstract: Neutrophilic dermatosis of the dorsal hands is considered a rare and localized variant of Sweet's syndrome. Although the etiology is unknown, there are reports of association with infections, neoplasias, autoimmune diseases and medications. Histopathology shows a dense neutrophilic inflammatory infiltrate in the dermis. Treatment is based on the administration of systemic corticosteroids; however, a combination of medications is useful, given the frequency of relapses. The authors report a classic and clinically exuberant case of neutrophilic dermatosis of the dorsal hands, with excellent response to oral dapsone treatment, and offer a brief literature review.
INTRODUCTION
Neutrophilic dermatoses represent a set of entities whose characteristic is the presence of an inflammatory infiltrate rich in neutrophils, without evidence of infectious agents, that can appear in localized cutaneous, generalized cutaneous and systemic forms. [1] [2] [3] Neutrophilic dermatosis of the dorsal hands (NDDH) presents morphological and histopathological characteristics resembling those of Sweet's syndrome (SS) and is considered a rare and localized variant of this syndrome. 1, 3, 4 The objective of this report is to present a classic and clinically exuberant case of NDDH that responded excellently to oral dapsone treatment, to highlight the rarity of this entity, and to offer a brief literature review. 
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In terms of comorbidities, the patient reported having hypertension and diabetes, and was using losartan and metformin. 
DISCUSSION
Described by Robert Douglas Sweet in 1964 as acute febrile neutrophilic dermatosis, SS is characterized by fever, leukocytosis, painful and erythematous plaques preferentially located on the face and extremities, and diffuse neutrophilic infiltrate in the dermis. 3, 5 NDDH was first described by Strutton et al. in 1995, considering six cases of women with lesions resembling SS, but located predominantly on the dorsum of hands. As the histopathological findings showed associated leukocytoclastic vasculitis, the entity was denominated pustular vasculitis of the hands. 6 Later, in 2000, Galaria et al. described three cases having clinical characteristics resembling the previously described pustular vasculitis of the hands, as well as dense neutrophilic dermal infiltrate, but without evidence of vasculitis. 7 Therefore, they proposed to rename the entity as NDDH, a variant of SS. 7 Currently, NDDH is a rare entity, with about 60 cases described in the literature. 1 It preferentially affects female patients with an average age of 62, commonly manifesting as papules, plaques, fertilizers. 1, 3, 5 None of these associations have been observed in the patient thus far.
The differential diagnoses of this entity include pyodermas, other neutrophilic dermatoses, and erythema elevatum diutinum.
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The treatment is based on the administration of systemic corticosteroids. However, given the frequency of relapse, the combination of dapsone and colchicine is useful, and they also serve as corticosteroid-sparing agents. Methotrexate, cyclosporin, azathioprine, indomethacin, minocycline, tetracycline, danazol, clofazimine, and potassium iodide are used less frequently. 1,9,10 Tacrolimus and topical corticosteroids can be used on small lesions with good results. 1, 10 In this report, the patient used only oral dapsone and presented nearly complete regression of the lesion after one month of treatment.
This classic and exuberant presentation, and the excellent response to the use of oral dapsone, motivated us to report this case and highlight the importance of knowledge about this entity and its possible associations, which is essential for its correct and complete management. q 
